摘要
目的 研究和分析钻孔引流微创联合术后尿激酶溶解治疗的可行性和价值. 方法 随机抽取于2014年1月—2015年1月,来该院神经外科住院治疗高血压脑出血患者120例作为研究对象并分组研究,其中观察组60例患者治疗上给予钻孔引流微创联合术后尿激酶溶解治疗,而对照组60例患者治疗上给予开颅骨瓣血肿清除术治疗,对比和分析两组患者的临床治疗效果. 结果 观察组总有效率为58（96.67%）,对照组总有效率为48（80.00%）,观察组患者的临床治疗效果比对照组更占据优势,并比较差异具有统计学意义（χ2=6.14,P〈0.05）. 结论 采取钻孔引流微创联合术后尿激酶溶解的方法对高血压脑出血患者治疗,疗效显著,有且有利于术后患者的恢复,值得临床推广.
Objective To study and analyze the feasibility and value of minimally invasive drilling drainage combined with urokinase clot lysis for treatment of hypertensive cerebral hemorrhage. Methods 120 patients with hypertensive cerebral hemorrhage hospitalized in the department of neurosurgery in this hospital from January 2014 and January 2015 were ran-domly selected as the research object. 60 of them in the observation group were treated with minimally invasive drilling drainage combined with urokinase clot lysis, while the other 60 in the control group underwent clearance of hematoma by craniotomy with bone flap. The clinical analysis of the patients was analyzed and compared between the two groups. Results The total effective rate [58（96.67%）vs 48（80.00%）] was higher in the observation group than in the control group, and the difference was statistically significant （χ2=6.14, P〈0.05）. Conclusion Minimally invasive drilling drainage combined with urokinase clot lysis in the treatment of patients with hypertensive cerebral hemorrhage can bring remarkable effect and is conducive to their postoperative rehabilitation. Therefore this method is worthy of promotion.
出处
《中外医疗》
2015年第32期108-109,118,共3页
China & Foreign Medical Treatment
关键词
高血压脑出血
钻孔引流
尿激酶
临床疗效
Hypertensive cerebral hemorrhage
Drainage
Urokinase
Treatment outcome
